Global Keloid Treatment Market With Strategic Trends, Growth, Revenue, and Forecast to 2027

1
Keloid Treatment Market , 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
Global Keloid Treatment Market was valued at USD
3620 Million in 2020 and is anticipated to grow
at USD 5372 Million till 2027 recording a CAGR of
5.8 during the forecast period
2021-2027. Excess of a protein in ones skin
during cure process after an injury causes raised
scar, which is known as keloid. Keloid treatment
greatly helps to flatten, soften and shrink the
keloid as they are tough to get rid of entirely.
Healthcare experts generally give combination
treatment for obtaining high treatment efficiency
rates. Keloid scar can reduce over a period.
Keloid scars are generally found in people of age
group 10-30 years Keloid scar cases are hugely
seen in Asian, African as well as American
People. Acquisitions, mergers, collaborations and
new product introduction are some of the
effective strategies followed by the industries
of the market in order to strengthen their place
in the market. For Instance, Lumenis acquired
An Israel aesthetic company named Pollogen Ltd
for expanding its product portfolio in the year
2015. Key players of this market are also
bringing new technologies in the market.

View Detailed
Report Description
3
Market Segments
The Global Keloid Treatment Market Has Been
Fragmented Based On 1. By Type Compression
Therapy, Intralesional Corticosteroid Injections,
Occlusive Dressing, Excision, Cryosurgery, Laser
Therapy, Radiation Therapy, Interferon
Therapy2. By End User Hospitals, Beauty
Centres, Dermatology Clinics, Others 3. By
Geography North America, Asia Pacific, Europe,
Middle East And Africa, Latin America Request
Sample Report
4
Key Players

• Some of the major key players in the Keloid
  Treatment Market are
• GlaxoSmithKline Plc. (UK),
• Avita Medical (UK),
• Pacific World Corporation (U.S.),
• Bristol-Myers Squibb Company (U.S.),
• Renovo Group plc. (UK),
• Novartis AG (Switzerland),
• Valeant Pharmaceuticals International Inc.,
  (Canada),
• RXi Pharmaceuticals, Inc. (U.S.)
• Galena Biopharma, Inc., (U.S.).
• Request Sample Report

5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553